BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21329465)

  • 1. A new method for FMR1 gene methylation screening by multiplex methylation-specific real-time polymerase chain reaction.
    Elias MH; Ankathil R; Salmi AR; Sudhikaran W; Limprasert P; Zilfalil BA
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):387-93. PubMed ID: 21329465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnosis of fragile X syndrome using methylation sensitive techniques in a cohort of patients with intellectual disability.
    Chaudhary AG; Hussein IR; Abuzenadah A; Gari M; Bassiouni R; Sogaty S; Lary S; Al-Quaiti M; Al Balwi M; Al Qahtani M
    Pediatr Neurol; 2014 Apr; 50(4):368-76. PubMed ID: 24630283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: testing in a clinical diagnostic laboratory.
    Nahhas FA; Monroe TJ; Prior TW; Botma PI; Fang J; Snyder PJ; Talbott SL; Feldman GL
    Genet Test Mol Biomarkers; 2012 Mar; 16(3):187-92. PubMed ID: 21992462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-tube methylation-specific duplex-PCR assay for rapid and accurate diagnosis of Fragile X Mental Retardation 1-related disorders.
    Rajan-Babu IS; Teo CR; Lian M; Lee CG; Law HY; Chong SS
    Expert Rev Mol Diagn; 2015 Mar; 15(3):431-41. PubMed ID: 25583300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A homogeneous assay for analysis of FMR1 promoter methylation in patients with fragile X syndrome.
    Dahl C; Grønskov K; Larsen LA; Guldberg P; Brøndum-Nielsen K
    Clin Chem; 2007 Apr; 53(4):790-3. PubMed ID: 17259243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simplified molecular diagnosis of fragile X syndrome by fluorescent methylation-specific PCR and GeneScan analysis.
    Zhou Y; Lum JM; Yeo GH; Kiing J; Tay SK; Chong SS
    Clin Chem; 2006 Aug; 52(8):1492-500. PubMed ID: 16793928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation analysis of the fragile X syndrome by PCR.
    Das S; Kubota T; Song M; Daniel R; Berry-Kravis EM; Prior TW; Popovich B; Rosser L; Arinami T; Ledbetter DH
    Genet Test; 1997-1998; 1(3):151-5. PubMed ID: 10464640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.
    Chen L; Hadd A; Sah S; Houghton JF; Filipovic-Sadic S; Zhang W; Hagerman PJ; Tassone F; Latham GJ
    Genet Med; 2011 Jun; 13(6):528-538. PubMed ID: 21430544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Validation of Fragile X Syndrome Screening by DNA Methylation Array.
    Schenkel LC; Schwartz C; Skinner C; Rodenhiser DI; Ainsworth PJ; Pare G; Sadikovic B
    J Mol Diagn; 2016 Nov; 18(6):834-841. PubMed ID: 27585064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Genetic Testing for Fragile X Syndrome by Polymerase Chain Reaction Amplification and Southern Blot Analyses.
    Cai X; Arif M; Wan H; Kornreich R; Edelmann LJ
    Methods Mol Biol; 2019; 1942():11-27. PubMed ID: 30900172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiplex methylation specific PCR analysis of fragile X syndrome: experience in Songklanagarind Hospital.
    Charalsawadi C; Sripo T; Limprasert P
    J Med Assoc Thai; 2005 Aug; 88(8):1057-61. PubMed ID: 16404832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular diagnosis of Fragile X syndrome.
    Sofocleous C; Kolialexi A; Mavrou A
    Expert Rev Mol Diagn; 2009 Jan; 9(1):23-30. PubMed ID: 19099346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1.
    Stöger R; Kajimura TM; Brown WT; Laird CD
    Hum Mol Genet; 1997 Oct; 6(11):1791-801. PubMed ID: 9302255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the polymerase chain reaction-based screening and the Southern blot methods for identification of fragile X syndrome.
    Curtis-Cioffi KM; Rodrigueiro DA; Rodrigues VC; Cicarelli RM; Scarel-Caminaga RM
    Genet Test Mol Biomarkers; 2012 Nov; 16(11):1303-8. PubMed ID: 23101592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of methylation sensitive polymerase chain reaction for detection of fragile X full mutation & carrier state in males.
    Karunasagar A; Pandit L; Kumar S; Karunasagar I; Karunasagar I
    Indian J Med Res; 2005 Nov; 122(5):429-33. PubMed ID: 16456258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size and methylation mosaicism in males with Fragile X syndrome.
    Jiraanont P; Kumar M; Tang HT; Espinal G; Hagerman PJ; Hagerman RJ; Chutabhakdikul N; Tassone F
    Expert Rev Mol Diagn; 2017 Nov; 17(11):1023-1032. PubMed ID: 28929824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Males with Cryptic Fragile X Alleles by Methylation-Specific Quantitative Melt Analysis.
    Aliaga SM; Slater HR; Francis D; Du Sart D; Li X; Amor DJ; Alliende AM; Santa Maria L; Faundes V; Morales P; Trigo C; Salas I; Curotto B; Godler DE
    Clin Chem; 2016 Feb; 62(2):343-52. PubMed ID: 26715660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advanced technologies for the molecular diagnosis of fragile X syndrome.
    Tassone F
    Expert Rev Mol Diagn; 2015; 15(11):1465-73. PubMed ID: 26489042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutation frequency in the FMR1 gene as revealed by fragile X syndrome screening.
    Handt M; Epplen A; Hoffjan S; Mese K; Epplen JT; Dekomien G
    Mol Cell Probes; 2014; 28(5-6):279-83. PubMed ID: 25171808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.